Recently, the China AMC Hangzhou Heda High-Tech Industrial Park Closed-End Infrastructure Securities Investment Fund (hereinafter referred to as "this Fund") has been listed and traded on the Shenzhen Stock Exchange. It is abbreviated as China AMC Heda High-Tech REIT in the market, and the listing and trading code is 180103. T&C Law Firm acted as the legal advisor of this Fund and provided legal services for the listing of this Fund.

This project is the first publicly-offered REITs of the biomedical industrial park nationwide and the first publicly-offered REITs project of the industrial park in Zhejiang province. The original equity holders of China AMC Heda High-Tech REIT are Hangzhou Heda High-Tech Development Group Co., Ltd. and Hangzhou Wanhai Investment Management Co., Ltd. The initial target assets for the offering are the Heda Pharmaceutical Valley Phase I and Incubator projects located in the Qiantang District. The number of fund units of China AMC Heda High-Tech REIT is 500 million, with a fundraising scale of 1.404 billion RMB. It was widely recognized by the market during the offering stage. The initial subscription multiple of offline investors was 155 times, and that of public investors was 271 times, attracting a total of over 98.1 billion RMB in capital participation.

T&C Law Firm provided all-round legal services for this fund and participated in all stages of this project throughout the process, including but not limited to assisting in determining the project plan, conducting compliance screening of underlying assets, issuing legal opinions, drafting and reviewing transaction documents, etc. The team members of this project include partners Liu Bin, Chen Xiaofeng, as well as lawyers Yu Xiaoyu and Du Xiaoyu.